These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16397559)

  • 41. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes.
    Saltiel AR
    Cell; 2001 Feb; 104(4):517-29. PubMed ID: 11239409
    [No Abstract]   [Full Text] [Related]  

  • 42. Metabolites as regulators of insulin sensitivity and metabolism.
    Yang Q; Vijayakumar A; Kahn BB
    Nat Rev Mol Cell Biol; 2018 Oct; 19(10):654-672. PubMed ID: 30104701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nuclear export-independent inhibition of Foxa2 by insulin.
    Howell JJ; Stoffel M
    J Biol Chem; 2009 Sep; 284(37):24816-24. PubMed ID: 19589781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Advances in the research on insulin mediators].
    Guo KQ
    Zhonghua Yi Xue Za Zhi; 1993 Jan; 73(1):54-6. PubMed ID: 8389235
    [No Abstract]   [Full Text] [Related]  

  • 45. MicroRNA-29 fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is dysregulated in animal models of insulin resistance and diabetes.
    Kurtz CL; Peck BC; Fannin EE; Beysen C; Miao J; Landstreet SR; Ding S; Turaga V; Lund PK; Turner S; Biddinger SB; Vickers KC; Sethupathy P
    Diabetes; 2014 Sep; 63(9):3141-8. PubMed ID: 24722248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unraveling the riddle of insulin resistance.
    Goldfine ID
    J Lab Clin Med; 1999 Aug; 134(2):100-2. PubMed ID: 10444021
    [No Abstract]   [Full Text] [Related]  

  • 47. [Aspects of prostaglandin involvement at the hepato-pancreatic level].
    Nechifor M
    Rev Med Chir Soc Med Nat Iasi; 1983; 87(1):56, 69, 70. PubMed ID: 6374812
    [No Abstract]   [Full Text] [Related]  

  • 48. Arsenic fatty acids are human urinary metabolites of arsenolipids present in cod liver.
    Schmeisser E; Rumpler A; Kollroser M; Rechberger G; Goessler W; Francesconi KA
    Angew Chem Int Ed Engl; 2005 Dec; 45(1):150-4. PubMed ID: 16307462
    [No Abstract]   [Full Text] [Related]  

  • 49. Genetically modified mouse models for disorders of fatty acid metabolism: pursuing the nutrigenomics of insulin resistance and type 2 diabetes.
    Wood PA
    Nutrition; 2004 Jan; 20(1):121-6. PubMed ID: 14698026
    [No Abstract]   [Full Text] [Related]  

  • 50. [Metabolic differentiation of insulin resistance in type 2 diabetes mellitus (non-insulin-dependent)].
    Czyzyk A
    Pol Arch Med Wewn; 1998 Jul; 100(1):2-8. PubMed ID: 10085708
    [No Abstract]   [Full Text] [Related]  

  • 51. [Behavior of liver lipids following the administration of vitamin K in rats on a steatogenic diet].
    CIANCIMINO C
    Boll Soc Ital Biol Sper; 1954 Jul; 30(7):912-3. PubMed ID: 14351515
    [No Abstract]   [Full Text] [Related]  

  • 52. Could the defect in type II diabetes mellitus be the absence of a postprandial alkalosis?
    Carlin K; Carlin S
    Med Hypotheses; 1994 Jul; 43(1):19-20. PubMed ID: 7968716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hunting for Fox(A2): Dual roles in female fertility.
    Cha J; Dey SK
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):1226-1228. PubMed ID: 28123060
    [No Abstract]   [Full Text] [Related]  

  • 54. Comments on the fate of and responses to insulin in the liver.
    STETTEN D
    Metabolism; 1959 Jul; 8(4 Pt 2):559-64. PubMed ID: 13666402
    [No Abstract]   [Full Text] [Related]  

  • 55. Foxa2 attenuates steatosis and inhibits the NF-κB/IKK signaling pathway in nonalcoholic fatty liver disease.
    Yang L; Ma Q; Chen J; Kong X; Yu X; Wang W
    PeerJ; 2023; 11():e16466. PubMed ID: 38084145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biochemical pathways represented by Gene Ontology-Causal Activity Models identify distinct phenotypes resulting from mutations in pathways.
    Hill DP; Drabkin HJ; Smith CL; Van Auken KM; D'Eustachio P
    Genetics; 2023 Oct; 225(2):. PubMed ID: 37579192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feeding during hibernation shifts gene expression toward active season levels in brown bears (
    Perry BW; McDonald AL; Trojahn S; Saxton MW; Vincent EP; Lowry C; Evans Hutzenbiler BD; Cornejo OE; Robbins CT; Jansen HT; Kelley JL
    Physiol Genomics; 2023 Sep; 55(9):368-380. PubMed ID: 37486084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biochemical Pathways Represented by Gene Ontology Causal Activity Models Identify Distinct Phenotypes Resulting from Mutations in Pathways.
    Hill DP; Drabkin HJ; Smith CL; Van Auken KM; D'Eustachio P
    bioRxiv; 2023 Jul; ():. PubMed ID: 37293039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases.
    Pérez-García A; Torrecilla-Parra M; Fernández-de Frutos M; Martín-Martín Y; Pardo-Marqués V; Ramírez CM
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ginger nanoparticles mediated induction of Foxa2 prevents high-fat diet-induced insulin resistance.
    Kumar A; Sundaram K; Teng Y; Mu J; Sriwastva MK; Zhang L; Hood JL; Yan J; Zhang X; Park JW; Merchant ML; Zhang HG
    Theranostics; 2022; 12(3):1388-1403. PubMed ID: 35154496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.